Skip to main content

Topic

FDA Approval

198 published works

  1. Health Industry Washington Watch

    Parallel CMS/FDA Review of Medical Products

    By Debra A. McCurdy

    On September 17, 2010, CMS and FDA published a notice announcing that they are considering establishing a process for overlapping evaluations of premarket, FDA-regulated medical products when the product sponsor…

  2. Reproductive Rights Prof Blog

    5-Day Emergency Contraceptive Approved by F.D.A. for Prescription Only

    By Reproductive Rights

    NY Times: F.D.A. Approves 5-Day Emergency Contraceptive, by Gardiner Harris: WASHINGTON — Federal drug regulators on Friday approved a new form of emergency contraceptive pill that prevents pregnancies if taken…

  3. Health Law Prof Blog

    FDA Advisory Panel Nixes “Pink Viagra”

    By HealthLawProf

    Flibanserin is a drug under consideration by the FDA for the treatment of Hypoactive Sexual Desire Disorder in women. An FDA advisory panel voted 10 to one that flibanserin was…

  4. Reproductive Rights Prof Blog

    Panel Recommends Approval of After-Sex Contraceptive Pill

    By Reproductive Rights

    NY Times: Panel Recommends Approval of After-Sex Pill, by Gardiner Harris: GAITHERSBURG, Md. — A federal advisory panel voted unanimously Thursday that federal drug regulators should approve a medicine that…

  5. Reproductive Rights Prof Blog

    FDA Says “Female Viagra” Performed Poorly in Studies

    By Reproductive Rights

    Salon.com: "Female viagra" leaves FDA unsatisfied, by Tracy Clark-Flory:Studies fail to prove that the so-called "pink pill" can fix women's sex drive The feverish excitement over a "female Viagra" prototype has…

  6. Dangerous Drugs & Medical Devices

    FDA Launches New Website To Show Safety Information Of New Drugs

    By Justinian Lane

    This is a great step towards greater transparency: WASHINGTON — The Food and Drug Administration launched a website Tuesday where patients and health care professionals can find safety information about…

  7. Reproductive Rights Prof Blog

    New Emergency Contraceptive Pill Prompts Debate

    By Reproductive Rights

    Wash. Post: New 'morning-after' pill, ella, raises debate over similarity to abortion drug, by Rob Stein: A French drug company is seeking to offer American women something their European counterparts…

  8. Drug & Device Law

    Managing the Michigan Diaspora

    By Bexis

    We haven’t heard the folks on the other side say it much, since ATRA’s pretty much taken over squatter’s rights to the phrase “Hellhole Jurisdiction,” but if they listed theirs,…

  9. California Personal Injury Law Case Notes

    FDA’s Role In Approving Yaz and Yasmin Examined

    By Kristine Keala Meredith

    The legal talk show Lawyer2Lawyer invited Mike Danko and an FDA expert, Professor James T. O'Reilly from the University of Cincinnati College of Law, to discuss Yaz and the Yaz lawsuits. …

  10. Health Industry Washington Watch

    Drugs Approved on the Basis of Surrogate Endpoints

    By Debra A. McCurdy

    This post was written by Paul Sheives. FDA is authorized to approve applications based on clinical trials that demonstrate a new drug’s impact on a “surrogate endpoint,” or laboratory measure…